Results for tag: "Chemotherapy Induced Anemia Drug"

Chemotherapy Induced Anemia (CIA) is a type of anemia caused by chemotherapy treatments. It is a common side effect of chemotherapy and can lead to fatigue, weakness, and shortness of breath. Treatment for CIA includes iron supplements, erythropoiesis-stimulating agents (ESAs), and blood transfusions. ESAs are the most commonly used drugs for treating CIA, as they stimulate the production of red blood cells. The CIA drug market is a subset of the larger hematological drugs market. It is composed of drugs used to treat anemia caused by chemotherapy, as well as other anemias. The market is expected to grow due to the increasing prevalence of cancer and the need for effective treatments. Some companies in the CIA drug market include Amgen, Johnson & Johnson, Novartis, Pfizer, and Roche. These companies produce a variety of drugs used to treat CIA, including ESAs, iron supplements, and blood transfusions. Show Less Read more